CMV and EBV-PTLD after liver transplantation

被引：7

作者：

So, S ^{[1
]}

机构：

[1] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA

来源：

TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 1-2期

关键词：

D O I：

10.1016/S0041-1345(00)02815-3

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1317 / 1319

页数：3

共 19 条

[1] Prophylaxis of cytomegalovirus infection in liver transplantation - A randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir [J].

Badley, AD ;

Seaberg, EC ;

Porayko, MK ;

Wiesner, RH ;

Keating, MR ;

Wilhelm, MP ;

Walker, RC ;

Patel, R ;

Marshall, WF ;

DeBernardi, M ;

Zetterman, R ;

Steers, JL ;

Paya, CV .

TRANSPLANTATION, 1997, 64 (01) :66-73

[2] Posttransplant lymphoproliferative disorders and gastrointestinal manifestations of Epstein-Barr virus infection in children following liver transplantation [J].

Cao, S ;

Cox, K ;

Esquivel, CO ;

Berquist, W ;

Concepcion, W ;

Ojogho, O ;

Monge, H ;

Krams, S ;

Martinez, O ;

So, S .

TRANSPLANTATION, 1998, 66 (07) :851-856

[3]

COX KL, 1995, TRANSPLANTATION, V59, P524

[4]

DESAI DM, 2000, PEDIATR TRANSPLANT, V4, pS2

[5] Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients [J].

Gane, E ;

Saliba, F ;

Valdecasas, GJC ;

OGrady, J ;

Pescovitz, MD ;

Lyman, S ;

Robinson, CA .

LANCET, 1997, 350 (9093) :1729-1733

[6] EPSTEIN-BARR VIRUS, IMMUNODEFICIENCY, AND B-CELL LYMPHOPROLIFERATION [J].

HANTO, DW ;

FRIZZERA, G ;

GAJLPECZALSKA, KJ ;

SIMMONS, RL .

TRANSPLANTATION, 1985, 39 (05) :461-472

[7] THE FREQUENCY OF EPSTEIN-BARR VIRUS-INFECTION AND ASSOCIATED LYMPHOPROLIFERATIVE SYNDROME AFTER TRANSPLANTATION AND ITS MANIFESTATIONS IN CHILDREN [J].

HO, M ;

JAFFE, R ;

MILLER, G ;

BREINIG, MK ;

DUMMER, JS ;

MAKOWKA, L ;

ATCHISON, RW ;

KARRER, F ;

NALESNIK, MA ;

STARZL, TE .

TRANSPLANTATION, 1988, 45 (04) :719-727

[8] Significance of detecting Epstein-Barr-Specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients [J].

Krieger, NR ;

Martinez, OM ;

Krams, SM ;

Cox, K ;

So, S ;

Esquivel, CO .

LIVER TRANSPLANTATION, 2000, 6 (01) :62-66

[9] Structure-activity relationships of L-dioxolane uracil nucleosides as anti-Epstein Barr virus [J].

Lin, JS ;

Kira, T ;

Gullen, E ;

Choi, Y ;

Qu, FC ;

Chu, CK ;

Cheng, YC .

JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (12) :2212-2217

[10]

MARTIN M, 1994, TRANSPLANTATION, V58, P779

← 1 2 →